The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases

Author： Ulanova Marina   Schreiber Alan D.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.20, Iss.1, 2006-01, pp. : 1-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antisense Oligonucleotides in Cancer: Recent Advances

By Lebedeva I.V.   Stein C.A.  

BioDrugs, Vol. 13, Iss. 3, 2000-03 ,pp. : 195-216

Adis International

Access to resources Recommend Favorite

A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides

By  

Annals Of Clinical And Translational Neurology, Vol. 1, Iss. 9, 2014-09 ,pp. : 703-720

John Wiley & Sons Inc

Access to resources Recommend Favorite

Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?

By Grünweller Arnold   Hartmann Roland K.  

BioDrugs, Vol. 21, Iss. 4, 2007-01 ,pp. : 235-243

Adis International

Access to resources Recommend Favorite

Comment on: A novel dysferlin‐mutant pseudoexon bypassed with antisense oligonucleotides

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 7, 2015-07 ,pp. : 783-784

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to comment on: A novel dysferlin mutant pseudoexon bypassed with antisense oligonucleotides

By  

Annals Of Clinical And Translational Neurology, Vol. 2, Iss. 7, 2015-07 ,pp. : 785-785

John Wiley & Sons Inc

Access to resources Recommend Favorite